Frederic D. Bushman

4 ta ish

University of Pennsylvania

1. CRISPR-engineered T cells in patients with refractory cancer

   Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis +38

   MaqolaOAOchiq kirish20203 iqtibos

   ABIABI:AkademIndex/2026.other.102870

2. QIIME allows analysis of high-throughput community sequencing data

   J. Gregory Caporaso, Justin Kuczynski, Jesse Stombaugh +24

   Boshqa20103 iqtibos

   ABIABI:AkademIndex/2026.other.405502

3. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

   Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons +35

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.475807

4. CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>

   Karlo Perica, Nayan Jain, Michael Scordo +23

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.475959